ECRY started at $.2570 first day of the promotion. Then it crashed to just under $.12 on three different occasions. I don't recall seeing NMED do that, in fact it has been a pretty strong and smooth ramp upward. Much more predictable than ECRY has been during (roughly) the same period. Share price of NMED is now well over $1 whereby Stocktips/ECRY isn't even close to that price. Stocktips needs to deliver on their promises or risk soon becoming as irrelevant as best damn penny stocks. Just sayin'...